References

Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy

10.1158/2159-8290.cd-15-1483 · 2016 · External reference

Integrating liquid biopsies into the management of cancer

10.1038/nrclinonc.2017.14 · 2017 · External reference

Treatment of retinoblastoma in 2015: agreement and disagreement

10.1001/jamaophthalmol.2015.3108 · 2015 · External reference

Aqueous humor markers in retinoblastoma, a review

10.1167/tvst.8.2.13 · 2019 · External reference

Genomic cfDNA analysis of aqueous humor in retinoblastoma predicts eye salvage: the surrogate tumor biopsy for retinoblastoma

10.1158/1541-7786.mcr-18-0369 · 2018 · External reference

Non-invasive diagnosis of retinoblastoma using cell-free DNA from aqueous humour

10.1136/bjophthalmol-2018-313005 · 2019 · External reference

Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: an MSKCC experience

2020 · External reference

Application of cell-free DNA analysis to cancer treatment

10.1056/nejmra1706174 · 2018 · External reference

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

10.1038/nature11156 · 2012 · External reference

Analysis of circulating tumor DNA to monitor metastatic breast cancer

10.1056/nejmoa1213261 · 2013 · External reference

Early change in circulating tumor DNA as a potential predictor of response to chemotherapy in patients with metastatic colorectal cancer

10.1038/s41598-019-53711-3 · 2019 · External reference

Cell-free DNA tumor fraction in the aqueous humor is associated with therapeutic response in retinoblastoma patients

10.1167/tvst.9.10.30 · 2020 · External reference

Molecular changes in retinoblastoma beyond RB1: findings from next-generation sequencing

10.3390/cancers13010149 · 2021 · External reference

Retrospective evaluation of somatic alterations in cell-free DNA from blood in retinoblastoma

2021 · External reference